L02BG04 • letrozole • Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors
Letrozole is an aromatase inhibitor used for the treatment of hormone-dependent breast cancer in postmenopausal women. It works by reducing estrogen levels, thereby inhibiting the growth of hormone-sensitive tumors.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include hot flashes, fatigue, joint pain, or osteoporosis. In rare cases, allergic reactions or liver disorders may occur.
Letrozole is not recommended for pregnant or breastfeeding women or patients with hypersensitivity to this medication.
Substance: letrozole
Date of last drug list: 01-06-2025
Commercial code: W55787007
Concentration: 2.5mg
Pharmaceutical form: tablets
Quantity: 30
Product type: generic
Price: 72.56 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: TEVA UK LTD - MAREA BRITANIE
Holder: TEVA PHARMACEUTICALS S.R.L. - ROMANIA
Number: 7778/2015/07
Shelf life: 3 years